Hold an Afternoon Tea This August, drink tea, eat cake, play games, and more to help fund our research and support.
Book a Public Health Talk Raise awareness of breast cancer in your local community or network by booking a free online or in-person talk.
Home About us Media Breast Cancer Now media statements 206 results We comment on new research which shows the drug trastuzumab deruxtecan may benefit even more breast cancer patients 05 Jun 2022 1 min read We respond to new findings from the Lumina trial which suggest some patients could avoid radiotherapy 07 Jun 2022 1 min read We respond to the Royal College of Radiologists’ clinical radiology and clinical oncology census reports for 2021 10 Jun 2022 1 min read We respond to research that suggests drugs that neutralise progesterone activity could be a potential risk-reducing treatment for women with altered BRCA genes 15 Jun 2022 1 min read We respond to the approval of breast cancer drug abemaciclib for routine use on the NHS 17 Jun 2022 2 min read Breast Cancer Now celebrates landmark victory as Trodelvy is recommended for use on the NHS in England 14 Jul 2022 2 min read Breast Cancer Now welcomes NICE decision to recommend alpelisib with fulvestrant for routine use on the NHS 14 Jul 2022 2 min read We respond to MP Dawn Butler's mission to find the Million Missing Mammograms 02 Aug 2022 1 min read We respond to Macmillan Cancer Support's warning that "almost 50,000 people are still missing a cancer diagnosis in the UK" 26 Nov 2021 1 min read We respond to a new report from The Institute of Cancer Research, London, into cancer clinical trials 09 Dec 2021 1 min read We respond to recent announcements around the COVID-19 booster jabs roll-out and share our concerns around potential disruption to breast cancer services caused by Omicron 13 Dec 2021 2 min read We respond to a new study showing how some cancer cells are able to resist PARP inhibitor drugs 11 Jan 2022 1 min read Previous 1 ... 12 ... 18 Next
We comment on new research which shows the drug trastuzumab deruxtecan may benefit even more breast cancer patients 05 Jun 2022 1 min read
We respond to new findings from the Lumina trial which suggest some patients could avoid radiotherapy 07 Jun 2022 1 min read
We respond to the Royal College of Radiologists’ clinical radiology and clinical oncology census reports for 2021 10 Jun 2022 1 min read
We respond to research that suggests drugs that neutralise progesterone activity could be a potential risk-reducing treatment for women with altered BRCA genes 15 Jun 2022 1 min read
We respond to the approval of breast cancer drug abemaciclib for routine use on the NHS 17 Jun 2022 2 min read
Breast Cancer Now celebrates landmark victory as Trodelvy is recommended for use on the NHS in England 14 Jul 2022 2 min read
Breast Cancer Now welcomes NICE decision to recommend alpelisib with fulvestrant for routine use on the NHS 14 Jul 2022 2 min read
We respond to Macmillan Cancer Support's warning that "almost 50,000 people are still missing a cancer diagnosis in the UK" 26 Nov 2021 1 min read
We respond to a new report from The Institute of Cancer Research, London, into cancer clinical trials 09 Dec 2021 1 min read
We respond to recent announcements around the COVID-19 booster jabs roll-out and share our concerns around potential disruption to breast cancer services caused by Omicron 13 Dec 2021 2 min read
We respond to a new study showing how some cancer cells are able to resist PARP inhibitor drugs 11 Jan 2022 1 min read
